TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 153 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,839,000 | +7.5% | 17,473 | +12.9% | 0.00% | 0.0% |
| Q3 2016 | $1,711,000 | -23.7% | 15,482 | +0.6% | 0.00% | -33.3% |
| Q2 2016 | $2,241,000 | +129.6% | 15,390 | +125.8% | 0.00% | +200.0% |
| Q1 2016 | $976,000 | +9.4% | 6,816 | +18.1% | 0.00% | 0.0% |
| Q4 2015 | $892,000 | +9811.1% | 5,770 | +9359.0% | 0.00% | – |
| Q3 2015 | $9,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |